Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07525258
- Status
- Recruiting
Conditions
- Alcohol Use Disorder
- Alcohol-associated Liver Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Implementation Intervention — BEHAVIORALA multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested.
Study Details
The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.
Key Dates
- Start date
- Apr 5, 2026
- Status verified
- May 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Hepatology CliniciansClinician participants will participate in a multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested. Participants will attend two approximately 60-minute-long educational sessions in which key points related to AUD treatment based on the HPCR resource and implementation facilitation intervention will be reviewed.
Primary Outcome Measure
Feasibility [ Time Frame: 12 months ]
Central Contacts
- Lamia Haque, MD MPH(203) 777-0304
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale School of Medicine/Yale-New Haven Health | New Haven | Connecticut | 06520 | - |
Find similar trials in New Haven, CT
By condition
By specialty
By research site
Related Studies
- Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)PHASE2 · Recruiting · VA Connecticut Healthcare System · West Haven, Connecticut
- TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV RiskRecruiting · University of Kentucky · New Haven, Connecticut
- Pregnenolone for the Treatment of Alcohol Use DisorderPHASE2 · Recruiting · Yale University · New Haven, Connecticut
- Emergency Department-Initiated Medications for Alcohol Use DisorderPHASE3 · Recruiting · Yale University · New Haven, Connecticut